Recent studies strongly suggest that oxidative stresses participate in ischemiaJreperfusion-induced neurode generation, In addition, heme oxygenase (HO) and major his tocompatibility complex (MHC) antigens serve as functional molecules against oxidative stress and as self-recognition markers in the immune system, respectively. In this study, we examined the induction of HO and MHC antigens in the rat hippocampus after transient forebrain ischemia. The protein level of HO-I was significantly enhanced after an episode of ischemia, After ischemia, HO-I expression was observed early but transiently in the CAl pyramidal neurons and later but One function of heme oxygenase (HO) (heme, hydro gen-donor:oxygen oxidoreductase [a-methene oxidizing, hydroxylating], EC 1. 14.99.3) is oxidation of the heme molecule in concert with NADPH-cytochrome P-450 reductase followed by the specific cleavage of heme into biliverdin, carbon monoxide, and iron (Maines, 1988) , Recent studies have indicated that there are at least two isozymes of HO, the inducible type (HO I) and the constitutive type (HO-2) (Maines, 1988) , In addition, the HO-1 protein, which has a molecular weight of 33 kDa, has been cloned (Shibahara et aI., 1985) and identified as heat shock protein-32 (HSP-32) in intact rat brain (Ewing and Maines, 1991; Ewing et aI., Abbreviations used: GFAP, glial fibrillary acidic protein; HO, heme oxygenase; HSP, heat shock protein; MHC, major histocompatibility complex; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling.
1992) and in cultured cells
. It has also been reported that one metabolite of heme, biliverdin, is rap idly metabolized by biliverdin reductase (bilirubin :NAD(Pt oxidoreductase, EC 1.3.1.24) to bilirubin, which is a powerful antioxidant (Stocker et aI., 1987 a,b; Llesuy and Tomaro, 1994) . In addition, HO is the rate limiting enzyme in the formation of bilirubin (Maines, 1988) . Induction of HO-1 may protect cells from oxida tive stress by increasing the formation of bilirubin (Nath et aI., 1992) and by fostering the sequestration of cata lytic iron with ferritin (Stocker et aI., 1987a) , It has been proposed that HO-l induction protects the kidney against oxidative damage after ischemia and reperfusion (Maines, 1993) , Major histocompatibility complex (MHC) antigens are surface glycoproteins that play a central role in self recognition in the immune system, These proteins are required for presentation of foreign antigens to CD4positive lymphocytes (Widera, 1986) . It is known that the CNS is an immunologically naive site from the fol lowing observations: (l) expression of MHC class I and class II antigens, which are critical for antigen presenta tion, is extremely low in the CNS; (2) the CNS is nearly devoid of a lymphatic system, which captures potential antigens; and (3) the blood-brain barrier imposes a com-plex barrier to cell extraversion from circulating blood. However, this naive nature is not absolute, as has been shown by the inability of foreign tissue grafts to survive indefinitely in the CNS and that rejection of the grafted tissue is accompanied by the upregulation of MHC an tigen expression. It has been reported that MHC antigens are induced in in vivo experimental animal models, such as by treatment with kainic acid (Akiyama et aI., 1988) , in optic nerve degeneration (Rao and Lund, 1993) , in jection with cytokines and lipopolysaccharide (Kitamura et aI., 1996) , and by experimental allergic encephalitis (Traugott and Lebon, 1988) and in human CNS diseases such as Alzheimer's disease (Tooyama et aI., 1990) and multiple sclerosis (Hayashi et aI., 1988) . These observa tions suggest that MHC antigens play a critical role in neuroimmunologic functions in the CNS.
In the transient forebrain ischemia model, it was re cently shown that terminal deoxynucleotidyl transferase mediated dUTP nick-end labeling (TUNEL) -positive pyramidal neurons stained weakly 3 days after treatment and strongly 7 days after treatment (Nitatori et aI., 1995) . Biochemically, it is well known that cells undergoing apoptosis are associated with cleavage of genomic DNA, and the fragmented genomic DNA can be histologically detected by the TUNEL-staining method (Gavrieli et aI., 1992) . Thus, the delayed neuronal death in the CA I is possibly caused by the apoptotic process. On the other hand, it also is known that the synthesis of many proteins decreases after cerebral ischemia (Kiessling et aI., 1986) and specific families of genes are induced, including the HSP genes and immediate early genes. In fact, mRNA and protein levels of HSP-70 were markedly increased after ischemia . However, it is unknown whether endogenous antioxidant factors, such as HO, are expressed in the neurodegenerative process by transient ischemia. In addition, the relationship be tween neuronal degeneration and immunologic activa tion is still unclear. In the present study, we examined whether HO-l and MHC antigens are induced by tran sient forebrain ischemia, and we also explored what type of glial cells express the HO-l protein.
MATERIALS AND METHODS

Animals and materials
Male Wistar rats, weighing between 180 and 220 g, were purchased from Charles River (Atsugi, Japan). The animals were acclimated to and maintained at 23°C under a 12-hour light/dark cycle. All animals were housed in standard labora tory cages and had free access to food and water throughout the study period. Institutional guidelines for experimental animal care were strictly observed. The experimental protocol was approved by the Committee for Animal Research at the Kyoto Pharmaceutical University.
The reagents used in this study were rabbit anti-rat heat shock protein-32 (HO-I ) and HO-2 purchased from Stress Gen (Victoria, Canada). Rabbit anti-HO-I and mouse anti-glial fi-brillary acidic protein (GFAP) antibodies were purchased from Chemicon International, Inc. (Temecula, CA, U.S.A.), and mouse monoclonal antibodies against rat CD II b (MRC OX-42) and rat MHC class I (MRC OXI8) and class II (MRC OX6) were purchased from Serotec Ltd. (Oxford, U.K.). The Bradford protein assay kit was purchased from BioRad Labo ratories (Hercules, CA, U.S.A.), the Vectastain ABC Elite kit was purchased from Vector Laboratories (Burlingname, CA, U.S.A.), and the enhanced chemiluminescence detection sys tem kit was purchased from Amersham (Buckinghamshire, U.K.).
Animal model
After the rats were fasted overnight with free access to water, they were subjected to transient forebrain ischemia as previ ously reported (Smith et a!., 1984) with slight modifications (Kaku et aI., 1993) . Rats were anesthetized briefly with 3.5% halothane, intubated, and connected to a Starling-type respira tor. Anesthesia was maintained with 0.7% halothane and 30% oxygen in nitrous oxide. The femoral artery and vein were exposed and silicone catheters were inserted for monitoring arterial blood pressure, arterial blood gases, and blood glucose levels. After isolation of the bilateral common carotid arteries, halothane was discontinued and rats were allowed to remain in a steady state for a period of 20 minutes, maintaining the rectal temperature at 37" ± 0.2°C, arterial Pa02 at 100 to 150 mm Hg, and Paco2 at 20 to 40 mm Hg. Transient forebrain ischemia was induced by clamping the bilateral carotid arteries and lowering the blood pressure to 50 mm Hg for 8 minutes while adminis tering trimetaphan camphor sulfonate and withdrawing blood from the venous catheter. After the 8-minute period of isch emia, the blood pressure was restored to normal levels by rapid reinfusion of the shed blood, and the bilateral carotid clamps were removed.
Immunoblotting and quantitative analysis
On days I, 3, and 7 after ischemia, the rats were sacrificed and the hippocampi were removed. The brains were homog enized in 50 mM Tris-HCl buffer (pH 7.4) containing I mM EGTA, I mM EDTA, I mM phenyl methyl sulfonyl fluoride, and I j.Lg/mL leupeptin. The homogenates were centrifuged at 50,000g at 4°C for 20 minutes, and the supernatant was used as the cytosolic fraction. The protein concentration was quantified by the Bradford protein assay kit according to the manufactur er's protocol.
Ten micrograms of cytosolic protein was run on an SDS polyacrylamide gel (12.5%) and then transferred to a poly vi nylidene difluoride membrane. To block nonspecific protein binding, membranes were incubated with 5% dehydrated skim milk and I % normal goat serum in Tris-buffered saline (pH 7.5) containing 0.3% Tween-20. The primary antibodies, anti HO-I (I: 10,(00) or anti-HO-2 (1 :500), were incubated with the membranes for I hour at room temperature and the en hanced chemiluminescence detection system kit was used for antibody detection.
For quantitative analysis, the X-ray film was scanned with a CCD color scanner (DuoScan, Agfa-Gevaert, Diisseldorf, Ger many) and analyzed using the NIH Image 1.56 program (writ ten by Wayne Rasband, National Institutes of Health, Bethesda, MD, U.S.A., and available from the internet by anonymous ftp from zippy.nimh.nih.gov). Statistical analysis was performed using a one-way analysis of variance. The BonferronilDunn posthoc test was used for group comparisons. Data are pre sented as the mean ± SD.
Tissue preparation, immunohistochemistry, and quantitative analysis
On days 1, 3, and 7 after ischemia, the animals were perfused through the left cardiac ventricle with ISO mL of 10 mM phos phate-buffered saline (pH 7.4) under deep anesthesia (sodium pentobarbital, 100 mg/kg, intraperitoneally), followed by 300 mL of cold fixative consisting of 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). After perfusion, the brain was quickly removed and treated for 2 days with fixativc at 4°C. After cryoprotection with 15% sucrose in phosphate buffer, the sections were cut into 20-jJ-m slices in a cryostat. Some of the sections were stained with hematoxylin-eosin (H-E) to exam ine the level of neuronal damage.
The free-floating sections were incubated with the anti HO-l antibody (1:10,000) for 4 days at 4°C. The antibody was detected with the ABC Elite Kit and labeling was revealed by incubation with 50 mM Tris-HCI buffer (pH 7.6) containing 0.02% 3,3' -diaminobenzidine and 0.0045% hydrogen peroxide with nickel enhancement using 0.6% nickel ammonium sulfate to obtain blue-stained positive products. For double immunostaining, anti-HO-I immunostained sections were incubated with 0.3% hydrogen peroxide to inactivate peroxi dase activity, and then incubated with antibody against CDllb (1:2,000), GFAP (1:4,000), MHC class I (1:200), or MHC class 11 (1:200) for 4 days at 4°C. The antibody was detected as described above, and labeling was revealed by in cubation with diaminobenzidine-hydrogen peroxide solution without nickel enhancement to obtain brown-stained products. For quantitative analysis, immunostained sections were scanned using a high-resolution camera (ProgRes 3008, Carl Zeiss, Jena, Germany) and then analyzed (WinRoof, Mitani Corp., Fukui, Japan). Data are presented as the mean ± SD. Immunostained sections were scanned using a high-resolution camera (ProgRes 3008) and the photographs were printed on a color photo printer (Pictrography 3000, Fuji Film, Tokyo, Ja pan).
A. HO-1 B. HO-2
RESULTS
Histologic changes in the hippocampus after ischemia Although cell death of the pyramidal neurons was not detected on day I after the 8-minute period of forebrain ischemia, changes in cell shape and eosinophilic somata with pyknotic nuclei were observed in the CAl subfield. The loss of pyramidal neurons in the CAl began to in crease 3 days after the 8 minutes of ischemia, and wide spread neuronal loss was observed on day 7. This obser vation confirms that delayed neural death occurred in this experimental cerebral ischemia model (data not shown).
Enhancement of HO-l protein in rat hippocampus after ischemia
The 33-kDa HO-I protein was detectable in the cyto solic fraction from the normal rat hippocampus ( Fig.  I A) . Although protein levels of HO-I did not change with the sham operation, HO-I expression levels were markedly enhanced on days I, 3, and 7 after ischemia (Fig. lA) . Conversely, the level of the 36-kDa HO-2 protein was detected in higher levels than the HO-l pro tein in the untreated hippocampus, and the expression level of HO-2 was not altered by the sham operation or by ischemia (Fig. IB) . Quantitatively, the level of the HO-I protein increased significantly on day 1 (227%, P < 0.05), day 3 (277%, P < 0.05), and day 7 (330%, P < 0.0 1) after ischemia (Fig. lA) , whereas the level of the HO-2 protein was unchanged (Fig. IB) . Changes of HO-I immunoreactivity in rat hippocampus after ischemia
In the normal and sham-operated rat hippocampus, HO-l immunoreactivity was distributed in a limited area, for example, in some of the neurons in the hilus of the dentate gyrus ( Fig. 2A) . Heme oxygenase-I immunore activity was induced in the CAl subfield, but was not induced in other subfields after ischemia ( Fig. 2B and C) . On day 1 after ischemia, HO-l immunoreactivity was observed in the pyramidal neurons in the CAl subfield (Figs. 2B, 3B and E) . Subsequently, on days 3 and 7 after ischemia, HO-I immunoreactivity was observed in the glial-like cells, but not in neurons in the CA 1 subfield (Figs. 2C, 3C, 3D and 3F ).
In the normal and sham-operated rat hippocampus, the CDIlb-immunoreactive microglia have many long, thin processes like the ramified type. After ischemia, numer- ous CD 11 b-immunoreactive microglia, which have short, thick processes like the ameboid type, were ob served in the neurodegenerative area of CAl (data not shown). On the other hand, GFAP-immunoreactive as trocytes were slightly _activated (data not shown). To clarify which cell type expresses HO-l , we further ex amined the double immunostaining with anti-HO-l an tibody and glial cell markers, for example, anti-CDllb antibody for microglia and anti-GFAP antibody for as trocytes. Heme oxygenase-I immunoreactivity was co localized predominantly with CDl lb immunoreactivity in ameboid microglia ( Fig. 4A and C) . However, HO-I immunoreactivity in GFAP-immunoreactive astrocytes was hard to detect ( Fig. 4B and D) .
Colocalization of HO-I with MHC antigens
In the normal and sham-operated rat hippocampus, neither MHC class I nor class II immunoreactivity was detectable. After ischemia, MHC immunoreactivities were induced in glial cells in the CAl subfield. After 3 days, the immunoreactivities of MHC class I and II in ameboid microglia were observed in the CA 1 subfield, but not in the other subfields in the hippocampal forma tion (data not shown). In addition, HO-l immunoreac tivity in ameboid microglia was mainly colocalized with MHC class II (Fig. 4F ) and little with class I (Fig. 4E ). Quantitative analysis shows almost all HO-l immunopositive microglia were MHC class II immuno reactive (Table 1) .
DISCUSSION
In in vivo rat hippocampus, it is known that the level of expression of HO-I mRNA is very low (Ewing et aI., 1992) , and HO-I immunoreactivity is observed in lim ited numbers of neurons (Vincent et aI., 1994) . Con versely, the HO-2 protein is more widely expressed in neurons (Vincent et aI., 1994) . Recently, it was sug gested that HO also functions as a defense system against oxidative stress, because biliverdin and bilirubin may act as physiologic antioxidants and potent scavengers of oxygen radicals (Stocker et aI., 1987a,b) . Because neu rons have low concentrations of glutathione and other antioxidants, bilirubin and biliverdin produced by HO may act as important antioxidants in stressed cells (Saud ers et aI., 1991) . Ascorbic acid protects excitatory amino acid-induced neuronal degeneration in the rat hippocam pus by serving as an antioxidant (MacGregor et aI., 1996) . In addition, recent studies strongly suggest that oxidati ve stresses participate in ischemiaireperfusion induced neurodegeneration (Kondo et aI., 1997) . In fact, stress-related proteins such as HSP-70 (Kinouchi et aI., 1993) , nuclear factor-KB (Salminen et aI., 1995) , and c-Fos (Uemura et aI., 1991) were expressed or activated by ischemia in animal models. Heat shock protein-70 (Sharp et aI., 1993) 1996) have also been expressed or activated in the hu man brain by ischemia. On the other hand, mRN A and protein of HO-I are reported to be induced by heat shock (Keyse and Tyrrell, 1989; Okinaga and Shibahara, 1993) , oxidative stress (Applegate et aI., 1991) , hypoxia (Mur phy et aI., 1991; Lavrosky et aI., 1993) , heme (Maines, 1988) , and injection of blood into the subarachnoid space (Matz et aI., 1996a (Matz et aI., ,b, 1997 . These observations suggest the possibility that HO-l is activated after ischemia. In fact, global and transient forebrain ischemia induced HO-l mRNA (Paschen et aI., 1994; Takeda et aI., 1994; respectively) , and focal ischemia induced HO-l protein in neurons in the regions of focal ischemia, and also in microglia throughout the ischemic hemisphere (Nimura et aI., 1996) . Although in the present study, HO-2 protein was con stitutively expressed in the normal rat hippocampus, the protein level remained unchanged after ischemia. On the other hand, recent studies have shown that excessive pro duction of nitric oxide by the inducible nitric oxide syn thase in glial cells also participates in delayed neuronal death in ischemia (Endoh et aI., 1994; Iadecola et aI., 1995) . It is also known that nitric oxide induces the S nitrosylation and ADP-ribosylation of cysteine residues in several enzymes, which results in a reduction of en zyme activity (BrUne et aI., 1994 ; Zhang et aI., 1994) . In contrast to rat and human HO-2 proteins, which contain three and two cysteine residues respectively, rat and hu man HO-l proteins each lack a cysteine residue (Mc Coubrey et aI., 1992 ; Rotenberg and Maines, 1990) , sug gesting that HO-l proteins may not be influenced by nitric oxide. In addition, HO-l and biliverdin reductase are resistant to heat shock whereas HO-2 is not (Ewing et aI., 1993; Maines, 1988) . The overexpression of HO-1 is associated with marked decreases in cell growth and DNA synthesis and increased survival in response to hyperoxic injury (Lee et aI ., 1996) .
In the present study, HO-l protein levels were signifi cantly enhanced in the hippocampus on days I, 3, and 7 after ischemia. On day 1, although neuronal death could not be detected, shape changes of the pyramidal neurons were observed in the CAl subfield, as well as the tran sient induction of HO-l. Between 3 and 7 days after J Cereb Blood Flow Metab, Vol. 18, No.8, 1998 ischemia, however, HO-l immunoreactivity in the neu rons was eliminated in conjunction with neuronal loss in the CA L It is known that HO-l produces not only bili verdin but also iron and carbon monoxide. Iron could lead to increased oxidative stress if not handled properly, and carbon monoxide is harmful. Therefore, it is still unclear whether induction of HO-l is helpful or harmful. Although protein synthesis in the CAl sub field is mark edly inhibited after ischemia (Kiessling et aI., 1986) , HO-l was induced in the CAl pyramidal neurons on day 1. However, the CAl pyramidal neurons died between day 3 and day 7. With respect to HO-l induction in CAl neurons, we consider two possibilities. First, heme as a substrate for HO-l in damaged CAl neurons is not enough to produce protective biliverdin. The second pos sibility is that harmful iron or carbon monoxide produced by HO-l causes delayed neuronal death. Thus, HO-l induction may be harmful rather than helpful to CA 1 neurons. Further studies of the function of HO-l in CA 1 pyramidal neurons are necessary before definitive con clusions can be drawn. On the other hand, HO-l was induced in the microglia between day 3 and day 7. Be cause heme might be released from dead neurons and activated microglia phagocytoses damaged neurons by scavenging in the CA 1 subfield (J0rgensen et aI., 1993) after 3 days, there is sufficient heme to produce biliver din, which is resistant to ischemia. In fact, many microg lia were still richly observed even after 7 days. In addi tion, overexpression of HO-I was associated with mark edly increased survival in response to hyperoxic oxidant injury (Lee et aI ., 1996) . Thus, delayed HO-I induction may be of benefit in microglia.
The immunoreactivity of HO-l increased dramatically in glial cells 3 days after ischemia. Double immunostain ing using the anti-HO-l antibody and glial cell markers clearly indicates that HO-l immunoreactivity was colo cali zed with CD I I b-immunoreacti ve microglia, but not with GFAP-immunoreactive astrocytes. It is known that CD 11 b-immunoreactive microglia contain many long, thin processes of the ramified type in the normal brain; however, numerous CDl l b-immunoreactive microglia with short, thick processes like the ameboid type were induced after ischemia (J0rgensen et aI., 1993) . In the present study, it was observed that numerous ameboid microglia appeared in the CAl subfield after ischemia, and HO-l immunoreactivity was seen predominantly in ameboid microglia and not in ramified microglia. Re cently, it has been reported that interleukin-113 and tumor necrosis factor-a, which play pivotal roles in a variety of inflammatory processes, were produced from microglia after focal cerebral ischemia (Buttini et aI., 1996) . In the present study, although MHC class I and II were also expressed 3 days after ischemia in microglia, HO-l im munoreactivity was predominantly colocalized with MHC class II antigens in ameboid microglia. Recent pa-pers have stated that kainic acid lesions induce MHC class II immunoreactive ameboid microglia (Akiyama et a!., 1988) and that reactive microglia, which express MHC class II antigens, have been observed phagocytos ing degenerated neuronal elements in Alzheimer's dis ease, Parkinson's disease, acquired immunodeficiency syndrome, and in other neuronal degenerative disorders (Dickson et aI., 1993; McGeer et aI., 1993) . These ob servations suggest that numerous ameboid microglia, in which HO-I protein was induced, may acquire resistance to oxidative stress and express MHC class II antigens, which can then have a neuroimmunologic function after ischemia.
In conclusion, we examined the induction of HO-I and MHC antigens in rat hippocampus after transient fore brain ischemia. The protein level of HO-l was signi ficantly enhanced after ischemia, although the level of the HO-2 protein was unchanged. Heme oxygenase-l was expressed early but transiently in pyramidal neurons and later but continuously in microglia in the CA I sub field. In addition, most of the HO-l -positive cells at day 7 were ameboid microglia, but not astrocytes. After tran sient forebrain ischemia, MHC class I or II antigens were also expressed in microglia. Double immunostaining showed that HO-l immunoreactivity in ameboid microg lia was predominantly colocalized with MHC class II antigens.
